Abstract Details
| Adam De Havenon, MD, FAAN (Yale University) | Dr. De Havenon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. De Havenon has or had stock in Certus.Dr. De Havenon has or had stock in TitinKM. The institution of Dr. De Havenon has received research support from NIH/NINDS. Dr. De Havenon has received publishing royalties from a publication relating to health care. |
| Anja Thormann, MD, PhD (Bispebjerg Hospital) | No disclosure on file |
| No disclosure on file | |
| Robert E. Hoesch, MD, PhD (Intermountain Healthcare) | No disclosure on file |
| No disclosure on file |